Temglip 1 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Glimepiride |
| Company | Team pharmaceuticals ltd |
| Also available as |
Title
Temglip Medicine
Categories
- Diabetes
- Medicine
- Healthcare
Description
Temglip is a sulfonylurea antidiabetic agent indicated to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone. It may be used concomitantly with metformin when diet, exercise, and Temglip or metformin alone does not result in adequate glycaemic control. It is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent.
Color Options
- White
Function
Lowers blood glucose levels by stimulating the release of insulin from pancreatic beta cells and improving the sensitivity of beta cells to glucose stimulus.
Dosage Range
1-6 mg daily
Dosage Administration
Must be swallowed with sufficient liquid
Drug Interaction
- Potentiates Hypoglycaemic Action:
- ACE inhibitors
- Fluconazole
- Guanethidine
- Attenuates Hypoglycaemic Action:
- Barbiturates
- Corticosteroids
- Nicotinic acid
- Masks Hypoglycaemic Attack Symptoms:
- Beta-receptor blockers
- Clonidine
- Guanethidine
Contraindications
- Insulin dependent (type I) diabetes mellitus
- Diabetic ketoacidosis
- Diabetic coma
- Hypersensitivity to Glimepiride or sulfonylureas
- Severe hepatic dysfunction
- Severe impairment of renal function
- Dialysis patients
Side Effects
- Hypoglycaemia
- Temporary visual impairment
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Urticaria
- Fall in blood pressure
Pregnancy and Lactation
Must not be taken during pregnancy or breastfeeding; insulin changeover is necessary
Precautions and Warnings
Initial weeks risk of hypoglycaemia necessitates careful monitoring
Overdose Effects
Can produce hypoglycaemia, necessitating immediate glucose intake or adjustment in drug dosage
Therapeutic Class
Sulfonylureas
Storage Conditions
Store below 30°C, away from light, and out of the reach of children